En | De
Sie sind hier: Onkologie » Urologische Tumoren 03. April 2020
Urologische Tumoren
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Endokrine Organe
Gynäkologische Tumoren
Urologische Tumoren
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 6345  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 126899  
[Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial].
Urologe A
von Amsberg G.
PMID: 32240319 [PubMed - as supplied by publisher]

Is testicular microlithiasis a really innocent condition? Its effects on oncological outcomes of germ cell testicular cancer: An observational study.
Arch Esp Urol
Selvi I, Sarikaya S, Ba.
PMID: 32240112 [PubMed - as supplied by publisher]

Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice.
Mazziotti G, Rodari M, Gelardi F, Tosi G, Zucali PA, Pepe G, Chiti A.
PMID: 32239451 [PubMed - as supplied by publisher]

Dietary Intakes of Trace Elements and the Risk of Kidney Cancer: The Singapore Chinese Health Study.
Nutr Cancer
Wang Y, Jafar TH, Jin A, Yuan JM, Koh WP.
PMID: 32238007 [PubMed - as supplied by publisher]

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
Nat Rev Urol
Meeks JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, Flaig TW, DeGraff DJ, Christensen E, Woolbright BL, McConkey DJ, Dyrskjøt L.
PMID: 32235944 [PubMed - as supplied by publisher]

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.
Cancers (Basel)
Regouc M, Belge G, Lorch A, Dieckmann KP, Pichler M.
PMID: 32235691 [PubMed]

Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation.
Cancers (Basel)
Xu H, Sun Y, Huang CP, You B, Ye D, Chang C.
PMID: 32235588 [PubMed]

Endophytic Renal Cell Carcinoma Treated with Robot-Assisted Surgery: Functional Outcomes - A Comprehensive Review of the Current Literature.
Urol Int
Khene ZE, Peyronnet B, Gasmi A, Verhoest G, Mathieu R, Bensalah K.
PMID: 32235126 [PubMed - as supplied by publisher]

The effect of atropine in preventing catheter-related pain and discomfort in patients undergoing transurethral resection due to bladder tumor; prospective randomized, controlled study.
Korean J Pain
, Ya, Akda, Ekici M, Demir E.
PMID: 32235018 [PubMed]

Stereotactic Body Radiotherapy Using CyberKnife® for Localized Low- and Intermediate-risk Prostate Cancer: Initial Report on a Phase I/II Trial.
Anticancer Res
Nakamura R, Hirata T, Suzuki O, Otani K, Kai N, Hatano K, Fujita K, Uemura M, Imamura R, Tanaka K, Yoshioka Y, Nonomura N, Ogawa K.
PMID: 32234896 [PubMed - in process]

Association of Nijmegen Breakage Syndrome 1 Genotypes With Bladder Cancer Risk.
Anticancer Res
Chen M, Chang WS, Shen TC, Gong CL, Lin ML, Wang ZH, Wang YC, Chen CH, Wu HC, Bau DT, Tsai CW.
PMID: 32234891 [PubMed - in process]

Real-Time Image-Guided Ablative Prostate Cancer Radiation Therapy: Results from the TROG 15.01 SPARK Trial.
Int J Radiat Oncol Biol Phys
Keall P, Nguyen DT, O'Brien R, Hewson E, Ball H, Poulsen P, Booth J, Greer P, Hunter P, Wilton L, Bromley R, Kipritidis J, Eade T, Kneebone A, Hruby G, Moodie T, Hayden A, Turner S, Arumugam S, Sidhom M, Hardcastle N, Siva S, Tai KH, Gebski V, Martin J.
PMID: 32234553 [PubMed - as supplied by publisher]

Patient-Reported Outcomes in a Phase 2 Study Comparing Atezolizumab Alone or With Bevacizumab Versus Sunitinib in Previously Untreated Metastatic Renal Cell Carcinoma.
Pal SK, McDermott DF, Atkins MB, Escudier B, Rini BI, Motzer RJ, Fong L, Joseph RW, Oudard S, Ravaud A, Bracarda S, Suarez C, Lam ET, Choueiri TK, Ding B, Quach C, Hashimoto K, Schiff C, Piault-Louis E, Powles T.
PMID: 32233107 [PubMed - as supplied by publisher]

How should radiologists incorporate non-imaging prostate cancer biomarkers into daily practice?
Abdom Radiol (NY)
Rajwa P, Syed J, Leapman MS.
PMID: 32232525 [PubMed - as supplied by publisher]

Early Diagnosis of Prostate Cancer from the Perspective of Chinese Physicians.
J Cancer
Yu W, Zhou L.
PMID: 32231732 [PubMed]

The immune infiltration in clear cell Renal Cell Carcinoma and their clinical implications: A study based on TCGA and GEO databases.
J Cancer
Pan Q, Wang L, Chai S, Zhang H, Li B.
PMID: 32231726 [PubMed]

Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer.
Abbastabar M, Sarfi M, Golestani A, Karimi A, Pourmand G, Khalili E.
PMID: 32231490 [PubMed]

Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
J Clin Med
Mennitto A, Huber V, Ratta R, Sepe P, de Braud F, Procopio G, Guadalupi V, Claps M, Stellato M, Daveri E, Rivoltini L, Verzoni E.
PMID: 32231117 [PubMed]

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol.
Methods Protoc
Norris JM, Kasivisvanathan V, Allen C, Ball R, Freeman A, Ghei M, Kirkham A, Whitaker HC, Kelly D, Emberton M.
PMID: 32231090 [PubMed]

External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer.
Cancers (Basel)
Bourbonne V, Fournier G, Vallières M, Lucia F, Doucet L, Tissot V, Cuvelier G, Hue S, Le Penn Du H, Perdriel L, Bertrand N, Staroz F, Visvikis D, Pradier O, Hatt M, Schick U.
PMID: 32231077 [PubMed]

   Artikel 1 - 20 / 126899    Seite 1 von 6345  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.



mehr >>


Sky right 1